Physician

David Carleton Reed, M.D.

According to 2025 Medicare claims, David Reed, M.D. (NPI: 1932330990) practices ophthalmology in the Barnstable Town, MA market, with the plurality of this provider's patient population coming from Barnstable, MA. This provider's primary affiliated billing organization is OPHTHALMIC CONSULTANTS OF BOSTON, INC. (NPI: 1437374428; TIN: 04-2500346) and primary practice location at 02673-2556. Reed is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Reed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,919 traditional Medicare patients, billed 97,083 HCPCS/CPT codes, and received $9,758,276 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 758 prescription claims across 209 beneficiaries totaling $60,206 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $956,971 to $9,758,276. Similarly, Part D prescription costs have risen steadily, from $6,330 to $60,206. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,348	5,301	$956,971
2016	1,583	10,159	$1,651,579
2017	2,064	14,519	$2,494,927
2018	2,461	20,993	$4,127,079
2019	2,769	24,166	$5,690,069
2020	2,736	23,436	$6,209,771
2021	3,238	31,368	$7,950,746
2022	2,914	39,236	$7,756,740
2023	2,878	63,690	$7,821,303
2024	2,919	97,083	$9,758,276

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	75	151	$6,330
2016	115	393	$19,398
2017	131	403	$18,523
2018	198	726	$49,656
2019	220	807	$76,227
2020	190	777	$77,634
2021	237	823	$72,687
2022	212	663	$71,094
2023	188	660	$70,988
2024	209	758	$60,206

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	487	6,846	$658
67028	Injection of drug into eye	889	5,328	$97
92014	Established patient complete exam of visual system	2,632	3,406	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	330	407	$67
92134	Imaging of retina	2,808	8,018	$31

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Bromfenac Sodium	Bromfenac Sodium	76	3,433	$18,755
Prolensa	Bromfenac Sodium	40	1,332	$13,698
Difluprednate	Difluprednate	81	3,243	$7,737
Prednisolone Acetate	Prednisolone Acetate	196	6,344	$6,080
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	78	5,580	$1,344

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for David Carleton Reed, M.D.?

Tedicare shows public-source Medicare data for David Carleton Reed, M.D. (NPI 1932330990), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Carleton Reed, M.D. have ACO affiliation data?

David Carleton Reed, M.D. is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to David Carleton Reed, M.D.?

David Carleton Reed, M.D. is linked to OPHTHALMIC CONSULTANTS OF BOSTON, INC. (billing NPI 1437374428) in the available physician profile data.

Does David Carleton Reed, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.